FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2961389662> ?p ?o ?g. }

• W2961389662 endingPage "1621" @default.
• W2961389662 startingPage "1610" @default.
• W2961389662 abstract "Since the discovery of proprotein convertase subtilisin/kexin type 9 (PCSK9) as an attractive target in the treatment of hypercholesterolemia, multiple anti-PCSK9 therapeutic modalities have been pursued in drug development. The objective of this research is to set the stage for the quantitative benchmarking of two anti-PCSK9 pharmacological modality classes, monoclonal antibodies (mAbs) and small interfering RNA (siRNA). To this end, we developed an integrative mathematical model of lipoprotein homeostasis describing the dynamic interplay between PCSK9, LDL-cholesterol (LDL-C), VLDL-cholesterol, HDL-cholesterol (HDL-C), apoB, lipoprotein a [Lp(a)], and triglycerides (TGs). We demonstrate that LDL-C decreased proportionally to PCSK9 reduction for both mAb and siRNA modalities. At marketed doses, however, treatment with mAbs resulted in an additional ∼20% LDL-C reduction compared with siRNA. We further used the model as an evaluation tool and determined that no quantitative differences were observed in HDL-C, Lp(a), TG, or apoB responses, suggesting that the disruption of PCSK9 synthesis would provide no additional effects on lipoprotein-related biomarkers in the patient segment investigated. Predictive model simulations further indicate that siRNA therapies may reach reductions in LDL-C levels comparable to those achieved with mAbs if the current threshold of 80% PCSK9 inhibition via siRNA could be overcome." @default.
• W2961389662 created "2019-07-23" @default.
• W2961389662 creator A5014797148 @default.
• W2961389662 creator A5024135249 @default.
• W2961389662 creator A5035224277 @default.
• W2961389662 creator A5047447621 @default.
• W2961389662 creator A5050618782 @default.
• W2961389662 creator A5057058540 @default.
• W2961389662 creator A5060396305 @default.
• W2961389662 creator A5060621476 @default.
• W2961389662 creator A5088429709 @default.
• W2961389662 date "2019-09-01" @default.
• W2961389662 modified "2023-10-13" @default.
• W2961389662 title "Comparative quantitative systems pharmacology modeling of anti-PCSK9 therapeutic modalities in hypercholesterolemia" @default.
• W2961389662 cites W161816689 @default.
• W2961389662 cites W162053157 @default.
• W2961389662 cites W1965130676 @default.
• W2961389662 cites W1989730880 @default.
• W2961389662 cites W1994130325 @default.
• W2961389662 cites W2001314633 @default.
• W2961389662 cites W2009220054 @default.
• W2961389662 cites W2012503689 @default.
• W2961389662 cites W2033589357 @default.
• W2961389662 cites W2037377195 @default.
• W2961389662 cites W2043704400 @default.
• W2961389662 cites W2056599701 @default.
• W2961389662 cites W2068201983 @default.
• W2961389662 cites W2080443045 @default.
• W2961389662 cites W2096075279 @default.
• W2961389662 cites W2102467926 @default.
• W2961389662 cites W2103487568 @default.
• W2961389662 cites W2106285889 @default.
• W2961389662 cites W2108956796 @default.
• W2961389662 cites W2110619762 @default.
• W2961389662 cites W2125876354 @default.
• W2961389662 cites W2126229169 @default.
• W2961389662 cites W2128030263 @default.
• W2961389662 cites W2134159541 @default.
• W2961389662 cites W2141191772 @default.
• W2961389662 cites W2141898196 @default.
• W2961389662 cites W2148577580 @default.
• W2961389662 cites W2164962892 @default.
• W2961389662 cites W2166934777 @default.
• W2961389662 cites W2168483013 @default.
• W2961389662 cites W2170384815 @default.
• W2961389662 cites W2417076517 @default.
• W2961389662 cites W2496801530 @default.
• W2961389662 cites W2518726365 @default.
• W2961389662 cites W2555483953 @default.
• W2961389662 cites W2595169180 @default.
• W2961389662 cites W2603199396 @default.
• W2961389662 cites W2609727004 @default.
• W2961389662 cites W2720343158 @default.
• W2961389662 cites W2953380254 @default.
• W2961389662 doi "https://doi.org/10.1194/jlr.m092486" @default.
• W2961389662 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6718444" @default.
• W2961389662 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31292220" @default.
• W2961389662 hasPublicationYear "2019" @default.
• W2961389662 type Work @default.
• W2961389662 sameAs 2961389662 @default.
• W2961389662 citedByCount "17" @default.
• W2961389662 countsByYear W29613896622020 @default.
• W2961389662 countsByYear W29613896622021 @default.
• W2961389662 countsByYear W29613896622022 @default.
• W2961389662 crossrefType "journal-article" @default.
• W2961389662 hasAuthorship W2961389662A5014797148 @default.
• W2961389662 hasAuthorship W2961389662A5024135249 @default.
• W2961389662 hasAuthorship W2961389662A5035224277 @default.
• W2961389662 hasAuthorship W2961389662A5047447621 @default.
• W2961389662 hasAuthorship W2961389662A5050618782 @default.
• W2961389662 hasAuthorship W2961389662A5057058540 @default.
• W2961389662 hasAuthorship W2961389662A5060396305 @default.
• W2961389662 hasAuthorship W2961389662A5060621476 @default.
• W2961389662 hasAuthorship W2961389662A5088429709 @default.
• W2961389662 hasBestOaLocation W29613896621 @default.
• W2961389662 hasConcept C159654299 @default.
• W2961389662 hasConcept C185592680 @default.
• W2961389662 hasConcept C203014093 @default.
• W2961389662 hasConcept C2778163477 @default.
• W2961389662 hasConcept C2778824825 @default.
• W2961389662 hasConcept C2778849439 @default.
• W2961389662 hasConcept C2780072125 @default.
• W2961389662 hasConcept C2780948078 @default.
• W2961389662 hasConcept C43554185 @default.
• W2961389662 hasConcept C542903549 @default.
• W2961389662 hasConcept C55493867 @default.
• W2961389662 hasConcept C62746215 @default.
• W2961389662 hasConcept C71924100 @default.
• W2961389662 hasConcept C8243546 @default.
• W2961389662 hasConcept C98274493 @default.
• W2961389662 hasConceptScore W2961389662C159654299 @default.
• W2961389662 hasConceptScore W2961389662C185592680 @default.
• W2961389662 hasConceptScore W2961389662C203014093 @default.
• W2961389662 hasConceptScore W2961389662C2778163477 @default.
• W2961389662 hasConceptScore W2961389662C2778824825 @default.
• W2961389662 hasConceptScore W2961389662C2778849439 @default.
• W2961389662 hasConceptScore W2961389662C2780072125 @default.
• W2961389662 hasConceptScore W2961389662C2780948078 @default.

• next